COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021

BACKGROUND: : Despite investigations on the effect of disease modifying therapies (DMTs) used in multiple sclerosis (MS) on coronavirus disease 2019 (COVID-19); there are still controversies. OBJECTIVE: : We designed this study to evaluate the epidemiological features of covid-19 in a large sample o...

Descripción completa

Detalles Bibliográficos
Autores principales: Naghavi, Saba, Kavosh, Aryan, Adibi, Iman, Shaygannejad, Vahid, Arabi, Sina, Rahimi, Maryam, Mazaheri, Shahbanoo, Ashtari, Fereshteh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519664/
https://www.ncbi.nlm.nih.gov/pubmed/35158427
http://dx.doi.org/10.1016/j.msard.2021.103335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519664/
https://www.ncbi.nlm.nih.gov/pubmed/35158427
http://dx.doi.org/10.1016/j.msard.2021.103335

Ejemplares similares